The State of Michigan's Department of Licensing and Regulatory Affairs and the Bureau of Medical Marihuana Regulation has opened public comment on a number of medical conditions and treatments that are being considered for addition to the state's medical marijuana policy.
Public comment will remain open and can be emailed up to 5:00 p.m. on May 3, 2018. You must put "Medical Marihuana Review Panel" in the subject line.
The conditions under consideration are: Anxiety, Depression, Obsessive Compulsive Disorder, Panic attacks, Schizophrenia, Social Anxiety Disorder, Arthritis, Rheumatoid Arthritis, Brain injury, Spinal cord injury, Asthma, Diabetes, Colitis, Gastric Ulcer, Inflammatory Bowel Disease, Ulcerative Colitis, Organ transplant, non-severe and non-chronic pain, Parkinson's, Tourette's Syndrome, Autism and Chronic pain.
A public hearing will be held on May 4, during which the Review Panel will make recommendations to the Department Director. It will be held at 9:00 a.m. in the Williams Building 1st Floor Auditorium at 525 W Ottawa St, Lansing, MI 48933.
The current list of debilitating medical conditions covered under Michigan's Medical Marijuana law include:
- Post-Traumatic Stress Disorder
- Positive status for Human Immunodeficiency Virus
- Acquired Immune Deficiency Syndrome
- Hepatitis C
- Amyotrophic Lateral Sclerosis
- Crohn's Disease
- Agitation of Alzheimer's disease
- Nail Patella, or the treatment of these conditions.
- A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following:
- Cachexia or Wasting Syndrome
- Severe and chronic pain
- Severe nausea
- Seizures, including but not limited to those characteristic of epilepsy
- Severe and persistent muscle spasms, including but not limited to those characteristic of multiple sclerosis
